about
Helus Pharma Inc, the commercial operating name of Cybin Inc, is a clinical-stage pharmaceutical company focused on developing proprietary neuroactive compounds, referred to as NSAs, which are synthetic molecules designed to target serotonin pathways...
Read More
5.11
-0.07
(-1.35%)
140.6K
XNAS Volume
XNAS 14 May, 2026 10:32 AM (EDT)
Not Eligible
Expensive Valuation
Technically Bearish
Helus Pharma Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..